Health care organizations should delay their general influenza vaccination campaigns by a month for the 2000-2001 flu season due to anticipated delays in availability of vaccine or outright shortages, the Center for Disease Control & Prevention's Advisory Committee on Immunization Practices recommended at its June 21 meeting.
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.
The UK’s research-based pharma industry and medical research charities have set out clear action points to drive greater diversity and inclusion in clinical trials.
Blenrep, GSK’s multiple myeloma therapy, faced a major setback when it was withdrawn from the market in 2022. The drug has since made a return as a second-line therapy, and is on track to being reimbursed in England.
